HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Günther, A. Articles by Seeger, W. Search for Related Content PubMed PubMed Citation Articles by Günther, A. Articles by Seeger, W.

Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties

Dept of Internal Medicine II, Justus-Liebig-University, Giessen, Germany

CORRESPONDENCE: W. Seeger, Medizinische Klinik II, Zentrum für Innere Medizin, Justus-Liebig-University, Klinikstr. 36, D-35392, Giessen, Germany. Fax: 49 6419942359. E-mail: Werner.Seeger@innere.med.uni-giessen.de

Keywords: acute respiratory distress syndrome, sepsis, surface tension, surfactant phospholipids

Received: May 9, 2001
Accepted January 9, 2002

The present study was supported by the Deutsche Forschungsgemeinschaft.

The purpose of the present study was to investigate the impact of bronchoscopic surfactant administration, on the biochemical and biophysical surfactant properties, in patients with severe and early acute respiratory distress syndrome (ARDS) and septic shock.

A total number of 27 ARDS patients received 300–500 mg·kg·body·weight^–1 of a natural bovine surfactant extract (Alveofact®) via a flexible bronchoscope. Bronchoalveolar lavages were performed 3 h prior to, and 15–18 h and 72 h after surfactant administration. A comparison to healthy volunteers, undergoing an identical lavage procedure, was made (control, n=12).

Severe biophysical and biochemical surfactant abnormalities were encountered throughout in the ARDS patients. These included a massive alveolar protein load, a reduced percentage of large surfactant aggregates (LA), a loss of palmitoylated phosphatidylcholine species and a significant reduction of surfactant apoprotein (SP)-A, SP-B and SP-C in the LA fraction. Both minimum (min) and adsorption (ads) surface tension values (pulsating bubble surfactometer) were dramatically increased. Surfactant treatment resulted in a marked increase in the lavagable phospholipid (PL) pool, but predominance of the alveolar surfactant-inhibitory protein load was still encountered. Far-reaching or even complete normalization of the PL profile, the LA fraction and its SP-B and SP-C (but not SP-A) content as well as the fatty acid composition of the phosphatidylcholine class was noted. Surface tension lowering properties (min and ads) significantly improved, but were still not fully normalized.

Bronchoscopic administration of large quantities of natural bovine surfactant in severe acute respiratory distress syndrome causes far-reaching restoration of biochemical surfactant properties and significant improvement, however not full normalization, of biophysical surfactant function.

This article has been cited by other articles:

				P. L. Ballard, J. D. Merrill, W. E. Truog, R. I. Godinez, M. H. Godinez, T. M. McDevitt, Y. Ning, S. G. Golombek, L. A. Parton, X. Luan, et al. Surfactant Function and Composition in Premature Infants Treated With Inhaled Nitric Oxide Pediatrics, August 1, 2007; 120(2): 346 - 353. [Abstract] [Full Text] [PDF]

				P. Markart, C. Ruppert, M. Wygrecka, T. Colaris, B. Dahal, D. Walmrath, H. Harbach, J. Wilhelm, W. Seeger, R. Schmidt, et al. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids Thorax, July 1, 2007; 62(7): 588 - 594. [Abstract] [Full Text] [PDF]

				J. A. Zasadzinski, T. F. Alig, C. Alonso, J. B. de la Serna, J. Perez-Gil, and H. W. Taeusch Inhibition of Pulmonary Surfactant Adsorption by Serum and the Mechanisms of Reversal by Hydrophilic Polymers: Theory Biophys. J., September 1, 2005; 89(3): 1621 - 1629. [Abstract] [Full Text] [PDF]

				I. Vadasz, R. E. Morty, M. G. Kohstall, A. Olschewski, F. Grimminger, W. Seeger, and H. A. Ghofrani Oleic Acid Inhibits Alveolar Fluid Reabsorption: A Role in Acute Respiratory Distress Syndrome? Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 469 - 479. [Abstract] [Full Text] [PDF]

				A. Hamvas, L. M. Nogee, F. V. White, P. Schuler, B. P. Hackett, C. B. Huddleston, E. N. Mendeloff, F.-F. Hsu, S. E. Wert, L. W. Gonzales, et al. Progressive Lung Disease and Surfactant Dysfunction with a Deletion in Surfactant Protein C Gene Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 771 - 776. [Abstract] [Full Text] [PDF]

				P. L. Ballard, J. D. Merrill, R. I. Godinez, M. H. Godinez, W. E. Truog, and R. A. Ballard Surfactant Protein Profile of Pulmonary Surfactant in Premature Infants Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1123 - 1128. [Abstract] [Full Text] [PDF]

				F. S. Cole Surfactant protein B: unambiguously necessary for adult pulmonary function Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L540 - L542. [Full Text] [PDF]

				A. Anzueto Exogenous surfactant in acute respiratory distress syndrome: more is better Eur. Respir. J., May 1, 2002; 19(5): 787 - 789. [Full Text] [PDF]

				D. Walmrath, F. Grimminger, D. Pappert, C. Knothe, U. Obertacke, A. Benzing, A. Gunther, T. Schmehl, H. Leuchte, and W. Seeger Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics Eur. Respir. J., May 1, 2002; 19(5): 805 - 810. [Abstract] [Full Text] [PDF]